{
    "2018-02-12": [
        [
            {
                "time": "2018-02-12",
                "original_text": "Health Care Sector Update for 02/12/2018: AXON,UTHR,NVO,FOLD,AVEO",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "AXON",
                        "UTHR",
                        "NVO",
                        "FOLD",
                        "AVEO"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-12",
                "original_text": "Noteworthy ETF Outflows: VEU, TD, SAP, NVO",
                "features": {
                    "keywords": [
                        "ETF Outflows",
                        "VEU",
                        "TD",
                        "SAP",
                        "NVO"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-02-12",
                "original_text": "Blog Exposure - Novo Nordiskâ€™s Ozempic is Approved in the EU for the Treatment of Type 2 Diabetes",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Ozempic",
                        "Approved",
                        "EU",
                        "Type 2 Diabetes"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-02-12",
                "original_text": "GlaxoSmithKline plc -- Moody's: M&A greatest downside risk to European pharma companies' credit quality in 2018",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "Moody's",
                        "M&A",
                        "downside risk",
                        "European pharma",
                        "credit quality"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-02-12",
                "original_text": "Better Buy: Pfizer Inc. (PFE) vs. Eli Lilly (LLY)",
                "features": {
                    "keywords": [
                        "Better Buy",
                        "Pfizer",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}